Medicure Inc.
MCUJF • Drug Manufacturers - Specialty & Generic
$1.82
▲ +0.03 (+1.68%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$10.02M
Growth
13.7%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 6.8%Consistent free cash flow · 4/5Manageable debt level · 0.07Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.82
Change1.68%
Market Cap$10.02M
52W Range0.67 - 0.97
Beta1.04
Gross Margin39.00%
Oper. Margin-23.87%
Profit Margin-24.60%
Debt/Eq0.07
Current Ratio1.02
Quick Ratio0.77
Revenue 5Y13.73%
Price$1.82
Change1.68%
Market Cap$10.02M
52W Range0.67 - 0.97
Beta1.04
Gross Margin39.00%
Oper. Margin-23.87%
Profit Margin-24.60%
Debt/Eq0.07
Current Ratio1.02
Quick Ratio0.77
Revenue 5Y13.73%
Volume7.70K
Avg Volume703.00
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
50/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 6.8%Consistent free cash flow · 4/5Manageable debt level · 0.07Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.